Press Releases
Hogan Lovells leads NONAGON to FDA 510(k) clearance for smartphone compatible telehealth device
19 April 2021
Director of Regulatory SciencesWashington, D.C.
Email michael.kasser@hoganlovells.com
Phone +1 202 637 5576
Fax +1 202 637 5910
LanguagesEnglish, Hebrew
Practice groupGlobal Regulatory
Michael (Moshe) Kasser has been involved in the regulation of medical devices since he obtained his Ph.D. in materials science and engineering. His thesis focused on novel materials used in joint replacement, and upon graduation, he immediately put this knowledge to use at the FDA as a scientific reviewer of orthopaedic devices. Michael brought a powerful and unique blend of the regulatory know-how and technical understanding required to comprehend and address the FDA's scientific concerns with novel technologies.
Today, Michael has combined that understanding with a knack for explaining technical concepts in a way that both the industry and FDA can easily understand. He uses his knowledge and communications skills to assist medical device companies to clear FDA hurdles and bring novel technologies to the U.S. market.
While he was at the FDA, Michael focused on novel technologies, such as combination products, Magnetic Resonance Imaging (MRI) safety testing of devices, and new biomaterials. He published articles in both scientific and regulatory journals on a variety of topics.
CDRH Special Recognition Award for work on MR Safety Public Workshop
Navy Meritorious Unit Commendation Award
Education
Ph.D. Materials Science and Engineering, University of Maryland, summa cum laude, 2009
B.S. Materials Science and Engineering, University of Maryland, magna cum laude, 2006
Memberships
Member, American Society for the Testing of Materials (ASTM), 2012-2013
Press Releases
19 April 2021
Sponsorships and Speaking Engagements
02 December 2020
News
27 October 2020
News
13 August 2019
News
19 April 2018
Hogan Lovells Publications
20 December 2017